Profil
Holger Lembrér formerly worked at Oncopeptides AB, as Chief Financial Officer in 2023, Boule Diagnostics AB, as Chief Financial Officer from 2024 to 2026, Ernst & Young AB, as Auditor from 2008 to 2011, and ASSA ABLOY AB, as Chief Financial Officer from 2011 to 2019.
Mr. Lembrér received his graduate degree from the University of Uppsala.
Dernières actualités sur Holger Lembrér
Anciens postes connus de Holger Lembrér
| Sociétés | Poste | Fin |
|---|---|---|
| BOULE DIAGNOSTICS AB | Directeur Général | 16/04/2024 |
| ONCOPEPTIDES AB | Directeur Financier/CFO | 13/11/2023 |
| ASSA ABLOY AB | Directeur Financier/CFO | 01/04/2019 |
Ernst & Young AB
Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services | Comptroller/Controller/Auditor | 01/09/2011 |
Formation de Holger Lembrér
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Assa Abloy AB
Assa Abloy AB Tools & HardwareConsumer Durables Manufactures and sells mechanical, electromechanical, digital door locks and smart home access solutions | Consumer Durables |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Boule Diagnostics AB
Boule Diagnostics AB Medical SpecialtiesHealth Technology Develops, manufactures, and markets medical tools | Health Technology |
Ernst & Young AB
Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services | Commercial Services |
















